NO941485L - Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse - Google Patents

Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse

Info

Publication number
NO941485L
NO941485L NO941485A NO941485A NO941485L NO 941485 L NO941485 L NO 941485L NO 941485 A NO941485 A NO 941485A NO 941485 A NO941485 A NO 941485A NO 941485 L NO941485 L NO 941485L
Authority
NO
Norway
Prior art keywords
nmr
concentration
vivo measurement
detectable
xenobiotic compound
Prior art date
Application number
NO941485A
Other languages
English (en)
Norwegian (no)
Other versions
NO941485D0 (no
Inventor
Michael F Tweedle
Harry William Strauss
Adrian D Nunn
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO941485D0 publication Critical patent/NO941485D0/no
Publication of NO941485L publication Critical patent/NO941485L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/448—Relaxometry, i.e. quantification of relaxation times or spin density
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO941485A 1993-04-23 1994-04-22 Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse NO941485L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/052,959 US5468467A (en) 1993-04-23 1993-04-23 Methods for the in vivo measurement of the concentration of non-imaging nmr-detectable xenobiotic compounds

Publications (2)

Publication Number Publication Date
NO941485D0 NO941485D0 (no) 1994-04-22
NO941485L true NO941485L (no) 1994-10-24

Family

ID=21981033

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941485A NO941485L (no) 1993-04-23 1994-04-22 Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse

Country Status (15)

Country Link
US (2) US5468467A (cs)
EP (1) EP0621491B1 (cs)
JP (1) JPH07374A (cs)
KR (1) KR100359898B1 (cs)
CN (1) CN1094938A (cs)
AT (1) ATE221208T1 (cs)
AU (1) AU6061394A (cs)
CA (1) CA2119345C (cs)
CZ (1) CZ89894A3 (cs)
DE (1) DE69431016T2 (cs)
FI (1) FI941832A7 (cs)
HU (1) HUT69795A (cs)
IL (1) IL109115A (cs)
NO (1) NO941485L (cs)
ZA (1) ZA942781B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753207A (en) * 1995-08-21 1998-05-19 Beth Israel Deaconess Medical Center, Inc. Use of paramagnetic compounds to measure temperature and pH in vivo
FI982069A7 (fi) * 1996-03-29 1998-11-10 Lawrence Berkeley Nat Laboratory NMR:n ja MRI:n tehostaminen hyperpolaroitujen jalokaasujen läsnä olles sa
US6319678B1 (en) * 1998-06-26 2001-11-20 Panvera Corporation Process for glucuronidation screening
US20040146847A1 (en) * 1998-12-07 2004-07-29 Trubetskoy Olga V. Process for glucuronidation screening
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US20030215391A1 (en) * 2001-07-19 2003-11-20 Carlos Rabito Fluorescent agents for real-time measurement of organ function
DE10230877A1 (de) * 2002-07-09 2004-02-12 Siemens Ag Kernspintomographiegerät mit einer Einrichtung zur graphischen Planung Kontrastmittel-gestützter angiographischer Messungen
WO2004066839A1 (en) * 2003-01-23 2004-08-12 University Of Florida Research Foundation, Inc. Method and apparatus for monitoring intravenous (iv) drug concentration using exhaled breath
US7939058B2 (en) * 2003-07-03 2011-05-10 University Of Southern California Uses of IL-12 in hematopoiesis
US20080085562A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of gadolinium chelates
US20080085563A1 (en) * 2006-10-10 2008-04-10 Idexx Laboratories, Inc. Detection of Gadolinium Chelates
KR100973063B1 (ko) * 2008-11-11 2010-07-29 경희대학교 산학협력단 층상 가돌리늄 히드록사이드 및 그를 포함하는 ｍｒｉ 조영제
JP5971677B2 (ja) * 2010-11-26 2016-08-17 東芝メディカルシステムズ株式会社 磁気共鳴診断装置、および、磁気共鳴スペクトロスコピーのデータ収集方法
EP2812716A4 (en) * 2012-02-08 2015-07-29 Anatech Advanced Nmr Algorithms Technologies Ltd DEVICE AND METHOD FOR THE NONINVASIVE MEASUREMENT OF BLOOD PARAMETERS
RU2625771C2 (ru) * 2012-05-23 2017-07-18 Дженентек, Инк. Способ отбора терапевтических средств
CN103217530B (zh) * 2013-03-26 2015-01-28 南昌大学 一种基于顺磁纳米Fe-Co合金探针间接富集的NMR食源性致病菌快速检测方法
CN103217449B (zh) * 2013-03-26 2016-02-24 南昌大学 一种基于顺磁纳米Fe-Ni合金探针间接富集的NMR食源性致病菌快速检测方法
ES2959411T3 (es) * 2013-11-13 2024-02-26 Nanonord As Método para la determinación cuantitativa de nitrógeno en un fluido acuoso
FR3039767B1 (fr) * 2015-08-04 2017-09-08 Guerbet Sa Composition destinee a vectoriser un agent anticancereux
WO2017147212A1 (en) * 2016-02-22 2017-08-31 The Regents Of The University Of California Compositions and methods for imaging cell populations
WO2023234979A2 (en) * 2021-12-20 2023-12-07 The Regents Of The University Of California High field magnetometry with hyperpolarized nuclear spins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49103693A (cs) * 1973-02-02 1974-10-01
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
US4837604A (en) * 1986-04-18 1989-06-06 Hypres, Inc. Femtosecond three-terminal switch and vertical tunnel junction
US4875486A (en) * 1986-09-04 1989-10-24 Advanced Techtronics, Inc. Instrument and method for non-invasive in vivo testing for body fluid constituents
ES2058714T3 (es) * 1987-06-23 1994-11-01 Nycomed Innovation Ab Mejoras introducidas en formacion de imagenes por resonancia magnetica.
US5234680A (en) * 1989-07-31 1993-08-10 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 NMR and/or MRI
US5236694A (en) * 1990-02-21 1993-08-17 The Board Of Regents, The University Of Texas System 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5100646A (en) * 1990-07-25 1992-03-31 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services NMR glomerular filtration test
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5250284A (en) * 1991-10-15 1993-10-05 Arnon Krongrad Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc

Also Published As

Publication number Publication date
KR940023442A (ko) 1994-11-17
NO941485D0 (no) 1994-04-22
EP0621491A2 (en) 1994-10-26
AU6061394A (en) 1994-10-27
EP0621491B1 (en) 2002-07-24
IL109115A (en) 1997-07-13
CN1094938A (zh) 1994-11-16
KR100359898B1 (ko) 2003-01-10
CA2119345C (en) 1999-10-26
EP0621491A3 (en) 1995-06-07
US5603917A (en) 1997-02-18
JPH07374A (ja) 1995-01-06
ATE221208T1 (de) 2002-08-15
HU9401166D0 (en) 1994-07-28
IL109115A0 (en) 1994-06-24
CZ89894A3 (en) 1995-02-15
ZA942781B (en) 1995-01-05
DE69431016D1 (de) 2002-08-29
CA2119345A1 (en) 1994-10-24
DE69431016T2 (de) 2003-03-27
FI941832A7 (fi) 1994-10-24
HUT69795A (en) 1995-09-28
FI941832A0 (fi) 1994-04-20
US5468467A (en) 1995-11-21

Similar Documents

Publication Publication Date Title
NO941485L (no) Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse
Murata et al. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension
Stimpson et al. Longitudinal changes in total body creatine pool size and skeletal muscle mass using the D3‐creatine dilution method
Aaronson et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies
Logan et al. Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology.
NO20081847L (no) Fremgangsmate for a forbedre kognitiv funksjon
Simons et al. Bilirubin binding to human liver ligandin (glutathione S-transferase).
Khan et al. Molecular modeling-based antioxidant arylidene barbiturates as urease inhibitors
Fall et al. Redox‐regulation of haemostasis in hypoxic exercising humans: a randomised double‐blind placebo‐controlled antioxidant study
Nogawa et al. Carbocisteine can scavenge reactive oxygen species in vitro
Degel et al. Cis‐Configured Aziridines Are New Pseudo‐Irreversible Dual‐Mode Inhibitors of Candida albicans Secreted Aspartic Protease 2
Petrosino et al. Cyanide overproduction impairs cellular bioenergetics in Down syndrome
Dong et al. Nanomolar level of ouabain increases intracellular calcium to produce nitric oxide in rat aortic endothelial cells
Shirotani et al. Generation of amyloid β peptide with pyroglutamate at position 3 in primary cortical neurons
Dovio et al. Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis
DK0788512T3 (da) Proinsulinpeptidforbindelser til detektion og behandling af Type I-diabetes
MXPA04004018A (es) Metodos de separacion por exclusion para toxicidad de compuestos de prueba.
ES2175123T3 (es) Procedimiento que sirve para determinar la concentracion de oxigeno enuna muestra.
WO2001077675A3 (en) Method for the prediction of preeclampsia and other diseases
NO20006086L (no) Fremgangsmåte for å redusere nivåer av homocystein og C- reaktive protein
Wenner et al. H+ changes associated with divalent cation uptake by mouse liver mitochondria
Urakawa et al. Ca uptake and tissue calcium in K-induced phasic and tonic contraction in taenia coli
Morelle et al. Proton, Mg2+ and protein as competing ligands for the fluorescent probe, mag‐indo‐1: a first step to the quantification of intracellular Mg2+ concentration
TR200103562T2 (tr) Amiloid proteini toplanmasını önleme ve amiloid birikintilerini görüntüleme yönteminde kullanım için rodanin türevleri
DK185984D0 (da) Disubstituerede polymethyleniminer,fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application